C. Coleman

发表

Thyroid carcinoma after high‐dose external radiotherapy for Hodgkin's disease. Report of three cases

I. Mcdougall, H. Kaplan, J. S. Burke, 1980, Cancer.

Leukemias, non-Hodgkin's lymphomas and solid tumors in patients treated for Hodgkin's disease

C. Coleman, 1982 .

Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement.

B. Silver, N. Tarbell, L. Shulman, 1997, International journal of radiation oncology, biology, physics.

Cardiac disease after mediastinal irradiation for seminoma

R. Gelman, T. Herman, J. Chaffey, 1987, Cancer.

Radiation-induced splenic atrophy in patients with Hodgkin's disease and non-Hodgkin's lymphomas.

H. Kaplan, M. Dailey, C. Coleman, 1980, The New England journal of medicine.

Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.

L. Kalish, B. Silver, N. Tarbell, 1995, The cancer journal from Scientific American.

Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trial.

B. Silver, N. Tarbell, L. Shulman, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.

L. Kalish, D. Rosenthal, L. Shulman, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sézary syndrome: a model for migration of T lymphocytes to skin.

R. Miller, I. Mcdougall, McDougall Ir, 1980, The New England journal of medicine.

Functional hyposplenia after splenic irradiation for Hodgkin's disease.

I. Mcdougall, H. Kaplan, M. Dailey, 1982, Annals of internal medicine.

Hematologic neoplasia in patients treated for Hodgkin's disease.

E. Glatstein, H. Kaplan, A. Flint, 1977, The New England journal of medicine.

Third-line chemotherapy for resistant Hodgkin's disease with lomustine, etoposide, and methotrexate.

S. Horning, S. Rosenberg, C. Jacobs, 1987, Cancer treatment reports.

In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients

H. Liber, K. Kelsey, J. O’Neill, 1991, Environmental and molecular mutagenesis.

Mutagenesis after cancer therapy.

H. Liber, K. Kelsey, M. Caggana, 1993, Environmental health perspectives.

Treatment of early-stage Hodgkin’s lymphoma

C. Coleman, 1999 .

Wide‐field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy

B. Silver, D. Rosenthal, N. Tarbell, 1993, Cancer.

Radiation therapy of seminoma: 17-year experience at the Joint Center for Radiation Therapy.

J. Richie, M. Jochelson, M. Garnick, 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

STUDIES ON MECHANISMS OF RESISTANCE TO CYTOSINE ARABINOSIDE: PROBLEMS IN THE DETERMINATION OF RELATED ENZYME ACTIVITIES IN LEUKEMIC CELLS

B. Chabner, D. Johns, C. Coleman, 1975, Annals of the New York Academy of Sciences.

The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience.

S. Rosenberg, R. Hoppe, H. Kaplan, 1982, Blood.

Lymphoblastic lymphoma in adults: results of a pilot protocol.

S. Rosenberg, J. Cohen, J. S. Burke, 1981, Blood.

Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis

L. Kalish, S. Hellman, M. Kadin, 1993, Cancer.

combined modality therapy: the Stanford experience The management of stage I--II Hodgkin's disease with irradiation alone or

R. Hoppe, H. Kaplan, R. Cox, 2011 .

A prospective study of hprt mutant and mutation frequencies in treated cancer patients.

H. Liber, K. Kelsey, M. Caggana, 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Risk of second cancers after treatment for Hodgkin's disease.

M. Tucker, S. Rosenberg, A. Varghese, 1988, The New England journal of medicine.

The treatment of malignant histiocytosis.

S. Horning, S. Rosenberg, R. Turner, 1984, Blood.

Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.

L. Kalish, B. Silver, N. Tarbell, 1996, Blood.

Treatment of lymphoblastic lymphoma in adults.

L. Weiss, V. Picozzi, R. Cox, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mutagenesis after therapy for Hodgkin's disease.

H. Liber, K. Kelsey, L. Shulman, 1993, Hematology/oncology clinics of North America.

Treatment of refractory non-Hodgkin's lymphomas of unfavorable histology with teniposide, cytarabine, and cisplatin.

S. Horning, S. Rosenberg, C. Jacobs, 1987, Cancer treatment reports.

Calculated prostate carcinoma volume

A. D'Amico, D. Schultz, S. Malkowicz, 1998, Cancer.

Status of Government-Funded Radiotherapy Services in Nigeria

T. Ige, D. Pistenmaa, C. Coleman, 2023, JCO global oncology.

Surveying the challenges of providing LINAC-based RT in Africa: A unique collaborative platform of all 28 African countries to improve access to treatment

Dosanjh, Manjit, D. Angal-Kalinin, 2021 .

External Beam Radiation of Tumors Alters Phenotype of Tumor Cells to Render Them Susceptible to Vaccine-Mediated T-Cell Killing

C. N. Coleman, C. Coleman, K. Camphausen, 2004, Cancer Research.

Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types).

C. Coleman, R. Dorfman, S. Rosenberg, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improved methodology for analyzing local and distant recurrence.

R. Gelber, C. Coleman, R. Gelman, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation.

James B. Mitchell, C. N. Coleman, W. Degraff, 2007, Cancer research.

Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer.

A. Renshaw, A. D'Amico, Ming-Hui Chen, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors for patients with hodgkin disease in first relapse

B. Silver, D. Rosenthal, H. Weinstein, 2022 .